The series on “Implementation of New Technology/Innovation in Surgery” is edited by Drs. Allan Tsung, MD & Aslam Ejaz, MD, MPH from The Ohio State University Wexner Medical Center, Columbus, OH, USA
Dr. Allan Tsung is a Professor and Chief of Surgical Oncology at the Ohio State University Wexner Medical Center. Dr. Tsung’s clinical interests center on evaluating and managing patients with liver, bile duct and pancreas cancers, with expertise in laparoscopic and robotic surgery. He has a research laboratory focused on the hypothesis that inflammatory responses can alter the local microenvironment, leading to cancer progression via tumor cell survival, expansion and metastases. His research also evaluates the contribution of molecular markers in the diagnosis and clinical management of patients with hepatobiliary and pancreas cancers and projects focusing on improving the access, delivery and quality of surgical oncology care. Dr. Tsung’s work has generated 180+ published peer-reviewed manuscripts in leading scientific journals and culminated in multiple principal investigator NIH R01 grants and many society and institutional grants. His long-term goal is to continue bringing bench side research breakthroughs to bedside clinical therapies.
Dr. Aslam Ejaz is a surgical oncologist who specializes in the treatment of pancreatic cancer, liver cancer, bile duct cancer and other gastrointestinal cancers. In addition to his clinical work, Dr. Ejaz enjoys teaching the future generation of surgeons and other cancer care providers as an assistant professor in the Division of Surgical Oncology at The Ohio State University. Dr. Ejaz’s clinical interest is in robotic minimally-invasive surgery, particularly in the treatment of complex hepato-pancreato-biliary disease. One of Dr. Ejaz’s research interests is in the development of clinical trials to help patients receive new therapies that may not be available at other treatment centers. Dr. Ejaz has helped develop and implement several clinical trials aimed at improving the treatment of cancer through new and innovative methods. He is also interested in researching how patients do after surgery as well as addressing variations in perioperative surgical care and quality improvement.
Series Outline:
- Establishing industry relationships and collaborations to new technology
- Artificial intelligence in the OR
- Establishing safety and efficacy
- Training and learning curve
- Innovation in Education
- Financial and infrastructural resources needed for new technology implementation
- Credentialing and ongoing quality improvement
- Ethical considerations when implementing new technology into OR
- Dissemination of new technology online on social media
- Evaluating new technology after implementation – long-term follow-up and quality control
Disclosure:
The series “Implementation of New Technology/Innovation in Surgery” was commissioned by the editorial office, Laparoscopic Surgery without any sponsorship or funding. Allan Tsung and Aslam Ejaz are serving as the unpaid Guest Editors for the series.
